Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
Clinical trial NCT01948986 · COMPLETED
Trial details
- NCT number
- NCT01948986
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2014-10-06
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.